SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001144204-18-055164
Filing Date
2018-10-24
Accepted
2018-10-24 17:02:24
Documents
2
Period of Report
2018-09-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tv505455_8-ka.htm 8-K/A 21269
2 EXHIBIT 10.1 tv505455_ex10-1.htm EX-10.1 66762
  Complete submission text file 0001144204-18-055164.txt   89385
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-20713 | Film No.: 181136968
SIC: 2836 Biological Products, (No Diagnostic Substances)